| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/05/2007 | EP1828153A1 N-(2-aminophenyl)-4-(5-((ethylamino)methyl)-1,3-thiazol-2-yl)benzamide and n-(2-aminophenyl)-4-(5-((isopropylamino)methyl)-1,3-thiazol-2-yl)benzamide as hdac inhibitors |
| 09/05/2007 | EP1828148A1 Triazole substituted aminobenzophenone compounds |
| 09/05/2007 | EP1828147A1 Quinoxalines as b-raf inhibitors |
| 09/05/2007 | EP1828144A2 Integrin antagonists useful as anticancer agents |
| 09/05/2007 | EP1828133A2 Methylene inhibitors of matrix metalloproteinase |
| 09/05/2007 | EP1828123A1 Indolinones and their use as antiproliferative agents |
| 09/05/2007 | EP1828115A2 2-methylene-19-nor-(20s)-1alpha-hydroxy-trishomopregnacalciferol |
| 09/05/2007 | EP1828114A2 17,20(e)-dehydro vitamin d analogs and their uses |
| 09/05/2007 | EP1828113A2 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses |
| 09/05/2007 | EP1827606A2 Aryl amide sphingosine 1-phosphate analogs |
| 09/05/2007 | EP1827605A1 Process for and intermediates in the preparation of canfosfamide and its salts, pharmaceutical compositions containing some intermediates, and their use as anticancer agents |
| 09/05/2007 | EP1827604A1 Methods and compositions for adoptive immunotherapy |
| 09/05/2007 | EP1827603A2 Novel pharmaceutical composition containing at least one dolastatin 10 derivative |
| 09/05/2007 | EP1827500A2 Pegylated liposomal doxorubicin in combination with ecteinescidin 743 |
| 09/05/2007 | EP1827492A2 Antibodies directed to gpnmb and uses thereof |
| 09/05/2007 | EP1827487A2 Cancer immunotherapy incorporating p53 |
| 09/05/2007 | EP1827437A2 Combinations of therapeutic agents for treating cancer |
| 09/05/2007 | EP1827434A2 Quinolines and quinazoline analogs and their use as medicaments for treating cancer |
| 09/05/2007 | EP1827430A1 Nanoparticulate benzothiophene formulations |
| 09/05/2007 | EP1827428A1 Compositions comprising an epothilone and production methods |
| 09/05/2007 | EP1827395A2 Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles, their manufacturing and their use for diagnostics and therapy |
| 09/05/2007 | EP1487811B1 N-sulfonylurea apoptosis promoters |
| 09/05/2007 | EP1474419B1 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2007 | EP1463760B1 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 09/05/2007 | EP1463733B1 Mitotic kinesin inhibitors |
| 09/05/2007 | EP1410802B1 Cell death inducers for mast cells |
| 09/05/2007 | EP1259541B1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 09/05/2007 | EP1093465B1 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 09/05/2007 | EP0993452B1 Angiogenesis inhibiting 5-substituted-1,2,4-thiadiazolyl derivatives |
| 09/05/2007 | CN200942187Y Selenium-enriched garlic piece |
| 09/05/2007 | CN101031638A Use of dendrimers to stimulate cell growth |
| 09/05/2007 | CN101031567A Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of t-cell proliferation and uses thereof |
| 09/05/2007 | CN101031566A Proline derivatives |
| 09/05/2007 | CN101031563A Benzimidazole derivatives, composition containing thereof and its preparation and application |
| 09/05/2007 | CN101031560A Cyclic diaryl ureas suitable as tyrosine kinase inhibitors |
| 09/05/2007 | CN101031551A Quinazoline modulators of hepatocyte growth factor / c-met activity for the treatment of cancer |
| 09/05/2007 | CN101031546A Isoindoline compounds and methods of making and using the same |
| 09/05/2007 | CN101031545A Isoindoline compounds and methods of their use |
| 09/05/2007 | CN101031339A Lysis/resealing process and device for incorporating an active ingredient in erythrocytes |
| 09/05/2007 | CN101031323A Conjugates of gm-csf moiety and a polymer |
| 09/05/2007 | CN101031319A Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs |
| 09/05/2007 | CN101031317A Methods for treating cancers |
| 09/05/2007 | CN101031316A Use of il-28 and il-29 to treat cancer and autoimmune disorders |
| 09/05/2007 | CN101031312A Anti-cancer compositions containing a shark meat extract and a mushroom extract |
| 09/05/2007 | CN101031311A Immunostimulator, method and apparatus for producing the same |
| 09/05/2007 | CN101031308A Prodrugs activated by rna-dependent dna-polymerases |
| 09/05/2007 | CN101031304A HCV inhibiting bi-cyclic pyrimidines |
| 09/05/2007 | CN101031301A 肿瘤的治疗 Cancer Treatment |
| 09/05/2007 | CN101029087A Method for separating polysaccharide against growth of cancer cells from dictyophord |
| 09/05/2007 | CN101029082A Recombination and preparation of human monocloned antibody against EGFR |
| 09/05/2007 | CN101029080A Methods and compositions for derepression of IAP-inhibited caspase |
| 09/05/2007 | CN101029073A Steroid saponin compound and its use in preparation antineoplastic |
| 09/05/2007 | CN101029069A Kaide glycoside 3-O-beta-Cima glycoside in white fleece-flower root and its use |
| 09/05/2007 | CN101029047A Isocoumarin compound with antineoplastic and antiulcer activities |
| 09/05/2007 | CN101029042A Bicyclic androgen and progesterone receptor modulator compounds and methods |
| 09/05/2007 | CN101029038A Benzofurantone compound, its production and use |
| 09/05/2007 | CN101028538A Medical devices containing rapamycin analogs |
| 09/05/2007 | CN101028525A Use of tumor caryon single-antibody in physical therapeutic tumor as synergist |
| 09/05/2007 | CN101028523A Method and compositions for the diagnosis and treatment of cancer |
| 09/05/2007 | CN101028520A Target magnetic nickel nano-medicinal preparation for inhibiting tumor cell growth and its production |
| 09/05/2007 | CN101028488A Chinese medicine for chronic pharyngitis, esophagus inflammation and esophagus cancer |
| 09/05/2007 | CN101028484A Chinese medicinal paste for treating tumor and its production |
| 09/05/2007 | CN101028482A Stomach-clearing pill |
| 09/05/2007 | CN101028471A Human-body synthetic gene ointment and its production |
| 09/05/2007 | CN101028418A Medicine for tumor |
| 09/05/2007 | CN101028389A Extraction of effective active ingredients with antitumor effect in saffron corm |
| 09/05/2007 | CN101028341A Magnoliaceae plant extract, its production and use |
| 09/05/2007 | CN101028322A Use of Maoliefengdou extract for preparing anti-cancer medicine |
| 09/05/2007 | CN101028314A Liquid coating against tumor, virus and bacterium |
| 09/05/2007 | CN101028309A Chinese medicine for treating tumor |
| 09/05/2007 | CN101028308A Chinese medicine for treating tumor |
| 09/05/2007 | CN101028305A Ganoderic spore extract and its production |
| 09/05/2007 | CN101028296A Chinese medicine for treating tumor |
| 09/05/2007 | CN101028293A Chinese medicine for treating esophagus cancer, stomach cancer and uterine cancer |
| 09/05/2007 | CN101028278A Medicinal effect of psilotopsida glucoside against cancers |
| 09/05/2007 | CN101028276A Instant pyrobixi freeze-drying powdery injection and its production |
| 09/05/2007 | CN101028259A Water soluble paclitaxel product |
| 09/05/2007 | CN101028253A Composition comprising epigallocatechin gallate |
| 09/05/2007 | CN101028251A Camptothecine derivative phosphatide composite liposome nano-preparation and its making method |
| 09/05/2007 | CN101028250A Garcinolic acid liposome and freezing-drying powdery preparation and its making method |
| 09/05/2007 | CN101028249A Anti-cancer composition containing neoformative vascular inhibitor and alkylating agent |
| 09/05/2007 | CN101028248A Anti-cancer composition containing vascular inhibitor and topographic enzyme inhibitor |
| 09/05/2007 | CN101028247A Anti-cancer composition containing neoformative vascular inhibitor and alkaloid |
| 09/05/2007 | CN101028246A Anti-cancer composition containing neoformative vascular inhibitor and hormone medicine |
| 09/05/2007 | CN101028245A Anti-cancer composition with neoformative vascular inhibitor and phosphoinositide 3-inositol inhibitor carrier |
| 09/05/2007 | CN101028244A Anti-cancer composition containing neoformative vascular inhibitor and antimetabolite |
| 09/05/2007 | CN101028243A Anti-cancer composition containing neoformative vascular inhibitor and Eps mycin |
| 09/05/2007 | CN101028132A 一种速溶香菇茶 Mushrooms of instant tea |
| 09/05/2007 | CN100335900C Novel self-assembly molecules |
| 09/05/2007 | CN100335633C Method for preparing N-end acetylation modified thymosin alpha with recombined E. coli |
| 09/05/2007 | CN100335628C Recombinant calmette-Guerin bacillus vaccine for secretion of human interferon-alphaza and its constructing method |
| 09/05/2007 | CN100335505C Process for preparing antrodia camphorata polysaccharide and antrodia camphorata triterpene with micro-prorous adsorptive resin and its product |
| 09/05/2007 | CN100335503C Polyol-ifn-beta conjugates |
| 09/05/2007 | CN100335499C C-terminal amino acid lactone modified extrasin alpha-1 and its uses |
| 09/05/2007 | CN100335496C Snake venom polypeptide and its preparation method |
| 09/05/2007 | CN100335479C Bicyclic inhibitors of glycogen synthase kinase 3 |
| 09/05/2007 | CN100335478C Chemokine receptor binding heterocyclic compounds |
| 09/05/2007 | CN100335464C Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 09/05/2007 | CN100335461C Arylsulfonanilide ureas |
| 09/05/2007 | CN100335137C Use of human homology cassette gene LHX4 in preparing medicine for treating phaeochromocytoma |